Sinjard
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with Empagliflozin is appropriate. And reduce the risk of heart failure and chronic kidney disease.
Features
| Product Name | Sinjard |
| Generic Name | Empagliflozin |
| Therapeutic Class | SGLT-2 inhibitor |
| Formulation | Tablet |
| Available Pack Size | 4 X 7’s & 2 X7’s |
| Available Strength | Available Strength 10 mg & 25 mg |